18033-Urothelial Cancer-NA-588

Urothelial Cancer

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients With Advanced or Metastatic Urothelial Carcinoma (516-003)

  • Details

ClinicalTrials.gov ID: NCT03606174
Diagnosis Type: NA
USOR Number:

  • Address

910 E Houston St, Suite 100
Tyler, TX 75702
P: (903) 579-9800

Search by practice name, trial titles, indicators and specific disease types.